EX1 0.00% 1.1¢ exopharm limited

Positive results for potential erectile dysfunction treatment

  1. 471 Posts.
    lightbulb Created with Sketch. 34

    Exopharm (EX1) delivers positive results for potential erectile dysfunction treatment



    • Exosome treatment researcher Exopharm (EX1) has found its Cevaris product to prove promising in treating erectile dysfunction
    • Exosomes are small sacs created by cells which can deliver therapies to other cells
    • The company wants to use exosomes to deliver stem cell therapies without the usual hassle

    Click to view full article

 
watchlist Created with Sketch. Add EX1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.